NYXOL
Live / Registered — Registered and renewed (as of 10 May 2018)
What this means for you
Registered since 06 May 2008. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 06 May 2018).
Record
- Serial number
- 78290032
- Registration number
- 3424007
- Mark type
- Word mark
- Filed
- 21 Aug 2003
- Published for opposition
- 21 Dec 2004
- Registered
- 06 May 2008
- Next maintenance due
- 06 May 2018
- Attorney of record
- Glenn A. Gundersen
Goods and services
- Class 005 — Pharmaceuticals: eye solutions and formulations for managing pupil size
Owner
- OPUS GENETICS, INC., DURHAM, NC, US
- Ocularis Pharma, Inc., North Riverside, IL, US
- Ocularis Pharma, Inc., North Riverside, IL, US
- Ocularis Pharma, Inc., North Riverside, IL, US
Prosecution history
- 26 Feb 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 19 Nov 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Nov 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 10 May 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 10 May 2018 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 10 May 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 10 May 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 May 2018 — TEAS SECTION 8 & 9 RECEIVED
- 06 May 2017 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 27 Feb 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 27 Feb 2014 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 12 Feb 2014 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 27 Feb 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Feb 2014 — TEAS SECTION 8 & 15 RECEIVED
- 06 May 2008 — REGISTERED-PRINCIPAL REGISTER